Patient Controlled Propofol Sedation Versus Standard Sedation in Advanced Therapeutic Colonoscopy With a Focus on Patient Satisfaction

NCT07637279 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-06-09

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if patient administered propofol sedation results in superior patient satisfaction compared to standard conscious sedation in advanced therapeutic endoscopy.

• Does self administration of the sedative propofol increase patient satisfaction? Researchers will compare patient administered propofol sedation (where the patient administers propofol by pushing a button) with standard conscious sedation

Participants will:

* Be randomized to either sedation route.
* Answer a preendoscopy questioneere and a postendoscopy questioneere 1 hour after the examination as well as one week after the examination.

Conditions

  • Colo-rectal Polyps

Interventions

DRUG

Patient controlled analgesia

Patient controlled propofol sedation. 5 mg propofol iv per push. Max 8 pushes/minute

DRUG

Standard medical treatment

Midazolam and/or fentanyl given intravenously as needed by endoscopy nurse

Sponsors & Collaborators

  • Danderyd Hospital

    collaborator OTHER
  • Capio Sankt Görans Hospital

    collaborator OTHER
  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Richard E Marsk, MD, Docent · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-11-01
Primary Completion
2028-06-15
Completion
2028-11-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07637279 on ClinicalTrials.gov